0 Commentaires
0 Parts
46 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
mRNA Cancer Vaccines Therapeutics Market Poised for Explosive Growth as Personalized Immunotherapy Revolutionizes OncologyThe global mRNA Cancer Vaccines Therapeutics Market is on an explosive growth trajectory, driven by the revolutionary potential of messenger RNA (mRNA) technology to transform cancer treatment through personalized immunotherapy. According to a comprehensive report by Wise Guy Reports, the market was valued at USD 3.6 billion in 2024. It is projected to grow from USD 4.3 billion in...0 Commentaires 0 Parts 358 Vue 0 Aperçu
-
Natural Killer (NK) Cell Therapeutics Market Size and Oncology Trends 2033The oncology landscape is shifting toward more sophisticated, "off-the-shelf" cellular interventions that leverage the body’s innate immune system. The Natural Killer (NK) Cell Therapeutics Market was valued at USD 504.09 million in 2024 and is projected to skyrocket to USD 9,839.77 million by 2032, growing at an extraordinary CAGR of 109.97% during the...0 Commentaires 0 Parts 395 Vue 0 Aperçu
-
Viral Infections to Autoimmunity: Diversifying Indications Expand the Natural Killer Cell Therapeutics Market Beyond Traditional OncologyThe natural killer (NK) cell therapeutics market is expanding beyond its oncology roots, with emerging applications in viral infections, autoimmunity, and even aging-related diseases. NK cells, known for their role in innate immunity, are particularly effective against viruses like HIV, hepatitis, and—more recently—SARS-CoV-2. In autoimmunity, they show potential to modulate...0 Commentaires 0 Parts 830 Vue 0 Aperçu
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Commentaires 0 Parts 253 Vue 0 Aperçu
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commentaires 0 Parts 240 Vue 0 Aperçu
-
How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...0 Commentaires 0 Parts 563 Vue 0 Aperçu
-
Mantle Cell Lymphoma Therapeutics Market Set for Strong Growth Through 2034The global healthcare and oncology sectors are witnessing rapid advancements in cancer therapeutics, particularly in the treatment of rare and aggressive blood cancers such as mantle cell lymphoma (MCL). Increasing awareness regarding early diagnosis, advancements in targeted therapies, and growing investments in oncology research are significantly contributing to industry expansion. The rising...0 Commentaires 0 Parts 68 Vue 0 Aperçu
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commentaires 0 Parts 259 Vue 0 Aperçu
-
What Breakthrough Drug Delivery Technologies Are Fueling the Peptide-Drug Conjugate Therapeutics Market?Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...0 Commentaires 0 Parts 482 Vue 0 Aperçu
-
Why Is Rising Demand for Nausea and Vomiting Treatments Expanding the Antiemetics Market?Latest Insights on Executive Summary Antiemetics Market Share and Size CAGR Value The global antiemetics market size was valued at USD 39.68 billion in 2025 and is expected to reach USD 61.87 billion by 2033, at a CAGR of 5.71% during the forecast period This Antiemetics Market research report is an absolute overview of the market that spans various aspects such as product definition,...0 Commentaires 0 Parts 503 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek